Chronic Lymphocytic Leukemia | Exploring Clinical Investigator Perspectives on the Optimal Management of Chronic Lymphocytic Leukemia (for Medical and Hematologic Oncologists) - a podcast by Dr Neil Love

from 2020-11-17T22:10:20

:: ::

Featuring perspectives from Dr Jennifer Woyach on the following topics:

  • Practical considerations in treatment of CLL for practicing clinicians — Jennifer Woyach, MD (0:00)
  • Case: A man in his early 60s with CLL with an IGHV mutation and deletion 13q receives ibrutinib/obinutuzumab on the control arm of the ECOG-EA9161 trial (26:25)
  • Case: A man in his mid-70s with relapsed/refractory CLL (30:45)
  • Case: A woman in her late 60s initially diagnosed with CLL with deletion 17p but no IGHV mutation undergoes Richter’s transformation (32:03)
  • Biomarker assessment to guide treatment selection in CLL (46:30)
  • Management of treatment-naïve CLL (52:42)
  • Treatment options for relapsed/refractory CLL CME information and select publications (1:25:14)

CME information and select publications

Further episodes of Research To Practice | Oncology Videos

Further podcasts by Dr Neil Love

Website of Dr Neil Love